Rapid Therapeutic Science Laboratories, Inc. (RTSL)

0.0050 0.0000 (0.00%) At close: 12:34PM EDT

Rapid Therapeutic Science Laboratories, Inc.

5580 Peterson Lane
Suite 120
Dallas, TX 75201
United States
800 497 6059
https://www.rtslco.com

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 3

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Donal R. Schmidt Jr.	President, CEO & Chairman	N/A	N/A	1961
Mr. D. Hughes Watler Jr.	CFO & Director	37.62k	N/A	1949
Dr. Duane C. Drinkwine Ph.D.	Chief Science Officer	N/A	N/A	N/A
Mr. Ryan C. Johnson	Vice President of Marketing	N/A	N/A	1975
Mr. Frank Gill	Chief Isolate Laboratory Technician	N/A	N/A	N/A
Mr. Sean Paul Berrier	Senior Vice President	N/A	N/A	N/A

Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Rapid Therapeutic Science Laboratories, Inc. operates as a biotech company, provides natural based relief through aerosol delivery systems for non-psychoactive cannabinoids. The company was formerly known as Holly Brothers Pictures, Inc. and changed its name to Rapid Therapeutic Science Laboratories, Inc. in January 2020. Rapid Therapeutic Science Laboratories, Inc. was incorporated in 2013 and is based in Dallas, Texas.

Corporate governance

Rapid Therapeutic Science Laboratories, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.